GILD logo

Gilead Sciences (GILD) EBIT

annual EBIT:

$1.67B-$6.14B(-78.64%)
December 31, 2024

Summary

  • As of today (April 19, 2025), GILD annual earnings before interest & taxes is $1.67 billion, with the most recent change of -$6.14 billion (-78.64%) on December 31, 2024.
  • During the last 3 years, GILD annual EBIT has fallen by -$7.61 billion (-82.03%).
  • GILD annual EBIT is now -92.54% below its all-time high of $22.35 billion, reached on December 31, 2015.

Performance

GILD EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

quarterly EBIT:

$2.42B+$1.22B(+102.35%)
December 31, 2024

Summary

  • As of today (April 19, 2025), GILD quarterly earnings before interest & taxes is $2.42 billion, with the most recent change of +$1.22 billion (+102.35%) on December 31, 2024.
  • Over the past year, GILD quarterly EBIT has increased by +$1.22 billion (+102.35%).
  • GILD quarterly EBIT is now -57.37% below its all-time high of $5.67 billion, reached on December 31, 2015.

Performance

GILD quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

TTM EBIT:

$1.67B+$511.00M(+44.17%)
December 31, 2024

Summary

  • As of today (April 19, 2025), GILD TTM earnings before interest & taxes is $1.67 billion, with the most recent change of +$511.00 million (+44.17%) on December 31, 2024.
  • Over the past year, GILD TTM EBIT has increased by +$511.00 million (+44.17%).
  • GILD TTM EBIT is now -92.54% below its all-time high of $22.35 billion, reached on December 31, 2015.

Performance

GILD TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GILD EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-78.6%+102.3%+44.2%
3 y3 years-82.0%+102.3%+44.2%
5 y5 years-72.9%+102.3%+44.2%

GILD EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.0%at low-9.2%+157.1%-79.8%+44.2%
5 y5-year-82.0%at low-34.5%+157.1%-83.9%+312.9%
alltimeall time-92.5%+1481.2%-57.4%+157.1%-92.5%+1482.1%

Gilead Sciences EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$1.67B(-78.6%)
$2.42B(+102.3%)
$1.67B(+44.2%)
Sep 2024
-
$1.19B(-47.9%)
$1.16B(-54.0%)
Jun 2024
-
$2.29B(-154.1%)
$2.51B(+23.1%)
Mar 2024
-
-$4.23B(-322.2%)
$2.04B(-73.8%)
Dec 2023
$7.80B(+15.6%)
$1.91B(-25.3%)
$7.80B(-4.3%)
Sep 2023
-
$2.55B(+40.3%)
$8.15B(-1.3%)
Jun 2023
-
$1.82B(+18.8%)
$8.27B(+0.9%)
Mar 2023
-
$1.53B(-32.2%)
$8.19B(+21.4%)
Dec 2022
$6.75B(-27.3%)
$2.26B(-15.2%)
$6.75B(+23.0%)
Sep 2022
-
$2.66B(+52.5%)
$5.49B(-15.8%)
Jun 2022
-
$1.75B(+1929.1%)
$6.52B(-4.8%)
Mar 2022
-
$86.00M(-91.4%)
$6.84B(-26.2%)
Dec 2021
$9.28B(+249.8%)
$997.00M(-73.0%)
$9.28B(-10.5%)
Sep 2021
-
$3.69B(+77.9%)
$10.36B(+34.0%)
Jun 2021
-
$2.07B(-17.8%)
$7.74B(+164.0%)
Mar 2021
-
$2.52B(+21.1%)
$2.93B(+10.4%)
Dec 2020
$2.65B(-56.9%)
$2.08B(+96.1%)
$2.65B(-2.3%)
Sep 2020
-
$1.06B(-138.8%)
$2.72B(+572.3%)
Jun 2020
-
-$2.73B(-221.8%)
$404.00M(-93.0%)
Mar 2020
-
$2.24B(+4.7%)
$5.79B(-5.8%)
Dec 2019
$6.16B(-30.7%)
$2.14B(-271.4%)
$6.16B(+16.5%)
Sep 2019
-
-$1.25B(-147.1%)
$5.28B(-44.2%)
Jun 2019
-
$2.66B(+2.1%)
$9.46B(+3.3%)
Mar 2019
-
$2.60B(+104.6%)
$9.16B(+3.2%)
Dec 2018
$8.88B(-39.4%)
$1.27B(-56.5%)
$8.88B(-11.5%)
Sep 2018
-
$2.93B(+24.5%)
$10.03B(-9.3%)
Jun 2018
-
$2.35B(+1.2%)
$11.06B(-15.5%)
Mar 2018
-
$2.32B(-4.1%)
$13.09B(-10.6%)
Dec 2017
$14.65B(-18.9%)
$2.42B(-38.8%)
$14.65B(-10.7%)
Sep 2017
-
$3.96B(-9.6%)
$16.41B(-3.3%)
Jun 2017
-
$4.38B(+13.0%)
$16.96B(-1.4%)
Mar 2017
-
$3.88B(-7.3%)
$17.21B(-4.7%)
Dec 2016
$18.06B(-19.2%)
$4.18B(-7.4%)
$18.06B(-7.6%)
Sep 2016
-
$4.52B(-2.3%)
$19.54B(-5.4%)
Jun 2016
-
$4.63B(-2.2%)
$20.66B(-4.7%)
Mar 2016
-
$4.73B(-16.5%)
$21.69B(-3.0%)
Dec 2015
$22.35B(+46.4%)
$5.67B(+0.5%)
$22.35B(+6.2%)
Sep 2015
-
$5.64B(-0.2%)
$21.04B(+11.5%)
Jun 2015
-
$5.65B(+4.8%)
$18.88B(+7.0%)
Mar 2015
-
$5.39B(+23.7%)
$17.64B(+15.5%)
Dec 2014
$15.27B(+238.2%)
$4.36B(+25.5%)
$15.27B(+26.2%)
Sep 2014
-
$3.48B(-21.2%)
$12.09B(+23.8%)
Jun 2014
-
$4.41B(+45.7%)
$9.77B(+49.9%)
Mar 2014
-
$3.02B(+155.1%)
$6.52B(+44.4%)
Dec 2013
$4.51B(+13.6%)
$1.19B(+2.8%)
$4.51B(+1.7%)
Sep 2013
-
$1.15B(+0.0%)
$4.44B(+2.6%)
Jun 2013
-
$1.15B(+12.9%)
$4.32B(+2.3%)
Mar 2013
-
$1.02B(-7.8%)
$4.23B(+6.4%)
Dec 2012
$3.97B(+3.0%)
$1.11B(+6.5%)
$3.97B(+5.7%)
Sep 2012
-
$1.04B(-1.7%)
$3.76B(+0.6%)
Jun 2012
-
$1.06B(+38.1%)
$3.74B(+0.8%)
Mar 2012
-
$766.10M(-14.3%)
$3.71B(-3.9%)
Dec 2011
$3.86B(-4.1%)
$893.84M(-12.2%)
$3.86B(+1.4%)
Sep 2011
-
$1.02B(-1.0%)
$3.80B(+0.6%)
Jun 2011
-
$1.03B(+12.3%)
$3.78B(+0.5%)
Mar 2011
-
$915.80M(+9.0%)
$3.76B(-6.5%)
Dec 2010
$4.02B(+12.6%)
$840.14M(-15.5%)
$4.02B(-5.6%)
Sep 2010
-
$994.67M(-1.6%)
$4.26B(+2.1%)
Jun 2010
-
$1.01B(-14.1%)
$4.17B(+6.0%)
Mar 2010
-
$1.18B(+9.3%)
$3.94B(+10.2%)
Dec 2009
$3.57B(+30.4%)
$1.08B(+18.5%)
$3.57B(+9.7%)
Sep 2009
-
$908.42M(+17.4%)
$3.25B(+7.1%)
Jun 2009
-
$773.98M(-4.7%)
$3.04B(+5.4%)
Mar 2009
-
$812.47M(+6.9%)
$2.89B(+4.4%)
Dec 2008
$2.74B(+26.5%)
$759.70M(+9.5%)
$2.76B(+9.7%)
Sep 2008
-
$693.83M(+12.0%)
$2.52B(+6.2%)
Jun 2008
-
$619.54M(-10.3%)
$2.37B(+3.3%)
Mar 2008
-
$690.75M(+34.3%)
$2.30B(+6.0%)
Dec 2007
$2.16B
$514.49M(-5.9%)
$2.16B(+1.4%)
Sep 2007
-
$547.03M(+0.8%)
$2.14B(+6.7%)
DateAnnualQuarterlyTTM
Jun 2007
-
$542.85M(-3.1%)
$2.00B(+9.7%)
Mar 2007
-
$560.14M(+15.4%)
$1.82B(+11.5%)
Dec 2006
$1.64B(+47.4%)
$485.22M(+17.5%)
$1.64B(+8.3%)
Sep 2006
-
$413.11M(+13.1%)
$1.51B(+12.3%)
Jun 2006
-
$365.31M(-1.7%)
$1.35B(+7.0%)
Mar 2006
-
$371.65M(+3.3%)
$1.26B(+13.4%)
Dec 2005
$1.11B(+76.8%)
$359.84M(+45.0%)
$1.11B(+21.8%)
Sep 2005
-
$248.25M(-10.5%)
$910.22M(+10.2%)
Jun 2005
-
$277.50M(+24.2%)
$825.74M(+16.9%)
Mar 2005
-
$223.48M(+38.8%)
$706.44M(+12.6%)
Dec 2004
$627.39M(+90.2%)
$161.00M(-1.7%)
$627.39M(+13.2%)
Sep 2004
-
$163.77M(+3.5%)
$554.37M(+18.0%)
Jun 2004
-
$158.20M(+9.5%)
$469.77M(+12.0%)
Mar 2004
-
$144.42M(+64.2%)
$419.35M(+27.1%)
Dec 2003
$329.92M(+307.3%)
$87.98M(+11.1%)
$329.92M(+20.1%)
Sep 2003
-
$79.17M(-26.5%)
$274.79M(+18.7%)
Jun 2003
-
$107.77M(+95.9%)
$231.53M(+62.0%)
Mar 2003
-
$55.00M(+67.5%)
$142.95M(+76.5%)
Dec 2002
$81.01M(-167.1%)
$32.84M(-8.6%)
$81.01M(+248.5%)
Sep 2002
-
$35.92M(+87.1%)
$23.24M(-147.7%)
Jun 2002
-
$19.19M(-376.5%)
-$48.74M(-52.1%)
Mar 2002
-
-$6.94M(-72.1%)
-$101.83M(-15.6%)
Dec 2001
-$120.69M(+130.7%)
-$24.92M(-30.9%)
-$120.69M(+5.5%)
Sep 2001
-
-$36.07M(+6.4%)
-$114.42M(+15.2%)
Jun 2001
-
-$33.90M(+31.4%)
-$99.29M(+39.8%)
Mar 2001
-
-$25.80M(+38.3%)
-$71.03M(+43.0%)
Dec 2000
-$52.32M(+1.2%)
-$18.65M(-10.9%)
-$49.68M(+119.5%)
Sep 2000
-
-$20.94M(+271.6%)
-$22.63M(-31.2%)
Jun 2000
-
-$5.63M(+26.6%)
-$32.89M(-17.0%)
Mar 2000
-
-$4.45M(-153.0%)
-$39.62M(-23.4%)
Dec 1999
-$51.70M(-34.0%)
$8.40M(-126.9%)
-$51.72M(-36.2%)
Sep 1999
-
-$31.20M(+152.4%)
-$81.02M(+13.4%)
Jun 1999
-
-$12.36M(-25.3%)
-$71.42M(-9.4%)
Mar 1999
-
-$16.55M(-20.8%)
-$78.85M(+5.8%)
Dec 1998
-$78.30M(+8.6%)
-$20.90M(-3.2%)
-$74.50M(-23.4%)
Sep 1998
-
-$21.60M(+9.1%)
-$97.20M(+7.2%)
Jun 1998
-
-$19.80M(+62.3%)
-$90.70M(+25.4%)
Mar 1998
-
-$12.20M(-72.0%)
-$72.30M(+0.4%)
Dec 1997
-$72.10M(+99.7%)
-$43.60M(+188.7%)
-$72.00M(+76.9%)
Sep 1997
-
-$15.10M(+978.6%)
-$40.70M(+102.5%)
Jun 1997
-
-$1.40M(-88.2%)
-$20.10M(-41.9%)
Mar 1997
-
-$11.90M(-3.3%)
-$34.60M(-3.9%)
Dec 1996
-$36.10M(+12.8%)
-$12.30M(-323.6%)
-$36.00M(+51.9%)
Sep 1996
-
$5.50M(-134.6%)
-$23.70M(-39.4%)
Jun 1996
-
-$15.90M(+19.5%)
-$39.10M(+21.4%)
Mar 1996
-
-$13.30M(+34.3%)
-$32.20M(-15.5%)
Dec 1995
-$32.00M(-9.1%)
-
-
Sep 1995
-
-$9.90M(+10.0%)
-$38.10M(+5.5%)
Jun 1995
-
-$9.00M(-10.0%)
-$36.10M(+2.6%)
Mar 1995
-
-$10.00M(+8.7%)
-$35.20M(+2.6%)
Mar 1995
-$35.20M(+19.3%)
-
-
Dec 1994
-
-$9.20M(+16.5%)
-$34.30M(+4.9%)
Sep 1994
-
-$7.90M(-2.5%)
-$32.70M(+3.5%)
Jun 1994
-
-$8.10M(-11.0%)
-$31.60M(+7.8%)
Mar 1994
-$29.50M(+62.1%)
-$9.10M(+19.7%)
-$29.30M(+8.1%)
Dec 1993
-
-$7.60M(+11.8%)
-$27.10M(+11.5%)
Sep 1993
-
-$6.80M(+17.2%)
-$24.30M(+14.6%)
Jun 1993
-
-$5.80M(-15.9%)
-$21.20M(+16.5%)
Mar 1993
-$18.20M(+188.9%)
-$6.90M(+43.8%)
-$18.20M(-1.6%)
Dec 1992
-
-$4.80M(+29.7%)
-$18.50M(+40.2%)
Sep 1992
-
-$3.70M(+32.1%)
-$13.20M(+41.9%)
Jun 1992
-
-$2.80M(-61.1%)
-$9.30M(+47.6%)
Mar 1992
-$6.30M(+31.3%)
-$7.20M(-1540.0%)
-$6.30M(+57.5%)
Dec 1991
-
$500.00K(+150.0%)
-$4.00M(-9.1%)
Sep 1991
-
$200.00K(0.0%)
-$4.40M(-2.2%)
Jun 1991
-
$200.00K(-104.1%)
-$4.50M(-2.2%)
Mar 1991
-$4.80M
-$4.90M(-5000.0%)
-$4.60M(-1633.3%)
Dec 1990
-
$100.00K(0.0%)
$300.00K(+50.0%)
Sep 1990
-
$100.00K(0.0%)
$200.00K(+100.0%)
Jun 1990
-
$100.00K
$100.00K

FAQ

  • What is Gilead Sciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Gilead Sciences?
  • What is Gilead Sciences annual EBIT year-on-year change?
  • What is Gilead Sciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Gilead Sciences?
  • What is Gilead Sciences quarterly EBIT year-on-year change?
  • What is Gilead Sciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Gilead Sciences?
  • What is Gilead Sciences TTM EBIT year-on-year change?

What is Gilead Sciences annual earnings before interest & taxes?

The current annual EBIT of GILD is $1.67B

What is the all time high annual EBIT for Gilead Sciences?

Gilead Sciences all-time high annual earnings before interest & taxes is $22.35B

What is Gilead Sciences annual EBIT year-on-year change?

Over the past year, GILD annual earnings before interest & taxes has changed by -$6.14B (-78.64%)

What is Gilead Sciences quarterly earnings before interest & taxes?

The current quarterly EBIT of GILD is $2.42B

What is the all time high quarterly EBIT for Gilead Sciences?

Gilead Sciences all-time high quarterly earnings before interest & taxes is $5.67B

What is Gilead Sciences quarterly EBIT year-on-year change?

Over the past year, GILD quarterly earnings before interest & taxes has changed by +$1.22B (+102.35%)

What is Gilead Sciences TTM earnings before interest & taxes?

The current TTM EBIT of GILD is $1.67B

What is the all time high TTM EBIT for Gilead Sciences?

Gilead Sciences all-time high TTM earnings before interest & taxes is $22.35B

What is Gilead Sciences TTM EBIT year-on-year change?

Over the past year, GILD TTM earnings before interest & taxes has changed by +$511.00M (+44.17%)
On this page